AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
for Solid Tumor Cancer
18 locations incl. Gilbert
Sponsor: Avenzo Therapeutics, Inc.
Sex: All·Age: 18 - 75
Code: NCT07038343·Phase 1, Phase 2·Recruiting